【结 构 式】 |
【分子编号】34376 【品名】(1S,3E)-5-[(2,5-dioxo-1-pyrrolidinyl)oxy]-1-[(1R,2E)-1-methyl-3-phenyl-2-propenyl]-5-oxo-3-pentenyl (2S)-2-([3-[(tert-butoxycarbonyl)amino]-2,2-dimethylpropanoyl]oxy)-4-methylpentanoate 【CA登记号】 |
【 分 子 式 】C35H48N2O10 【 分 子 量 】656.7736 【元素组成】C 64.01% H 7.37% N 4.27% O 24.36% |
合成路线1
该中间体在本合成路线中的序号:(X)The known methyl ester (VI was hydrolyzed to carboxylic acid (VII) with LiOH in aqueous acetone. After conversion of (VII) to the corresponding succinimidyl ester with N-hydroxysuccinimide and EDC, fluoride-mediated desilylation under acidic conditions furnished alcohol (VIII). Subsequent esterification of (VIII) with the protected amino acid (IX) using EDC and a catalytic amount of DMAP provided intermediate (X). Then, chemoselective coupling of (X) with amino acid (V) was achieved in the presence of N,O-bis(trimethylsilyl)acetamide (BSA) in hot DMF to afford the acyclic precursor (XI). After removal of the Boc group of (XI) with trifluoroacetic acid, the resulting amino acid (XII) was converted to the cyclic depsipeptide (XIII) by macrolactonization under high dilution conditions in the presence of pentafluorophenyl diphenylphosphinate. The aryl amine of (XIII) was protected as the Fmoc derivative (XIV).
【1】 Schultz, R.M.; Andis, S.L.; Ray, J. E.; Patel, V.F.; Kennedy, J.H.; Novel cryptophycin antitumor agents: Synthesis and cytotoxicity of fragment "B" analogues. J Med Chem 1999, 42, 14, 2588. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
40597 | 9-[[(chlorocarbonyl)oxy]methyl]-9H-fluorene | 28920-43-6 | C15H11ClO2 | 详情 | 详情 | |
(V) | 34372 | (2R)-2-amino-3-(4-amino-3-chlorophenyl)propionic acid | C9H11ClN2O2 | 详情 | 详情 | |
(VI) | 34373 | methyl (2E,5S,6R,7E)-5-[[tert-butyl(dimethyl)silyl]oxy]-6-methyl-8-phenyl-2,7-octadienoate | C22H34O3Si | 详情 | 详情 | |
(VII) | 34374 | (2E,5S,6R,7E)-5-[[tert-butyl(dimethyl)silyl]oxy]-6-methyl-8-phenyl-2,7-octadienoic acid | C21H32O3Si | 详情 | 详情 | |
(VIII) | 34375 | 1-[[(2E,5S,6R,7E)-5-hydroxy-6-methyl-8-phenyl-2,7-octadienoyl]oxy]-2,5-pyrrolidinedione | C19H21NO5 | 详情 | 详情 | |
(IX) | 18904 | (2S)-2-([3-[(tert-butoxycarbonyl)amino]-2,2-dimethylpropanoyl]oxy)-4-methylpentanoic acid | C16H29NO6 | 详情 | 详情 | |
(X) | 34376 | (1S,3E)-5-[(2,5-dioxo-1-pyrrolidinyl)oxy]-1-[(1R,2E)-1-methyl-3-phenyl-2-propenyl]-5-oxo-3-pentenyl (2S)-2-([3-[(tert-butoxycarbonyl)amino]-2,2-dimethylpropanoyl]oxy)-4-methylpentanoate | C35H48N2O10 | 详情 | 详情 | |
(XI) | 34377 | (10S,13S,15E,19R)-19-(4-amino-3-chlorobenzyl)-10-isobutyl-2,2,7,7-tetramethyl-13-[(1R,2E)-1-methyl-3-phenyl-2-propenyl]-4,8,11,17-tetraoxo-3,9,12-trioxa-5,18-diaza-15-icosen-20-oic acid | C40H54ClN3O9 | 详情 | 详情 | |
(XII) | 34378 | (2R)-3-(4-amino-3-chlorophenyl)-2-[[(2E,5S,6R,7E)-5-([(2S)-2-[(3-amino-2,2-dimethylpropanoyl)oxy]-4-methylpentanoyl]oxy)-6-methyl-8-phenyl-2,7-octadienoyl]amino]propionic acid | C35H46ClN3O7 | 详情 | 详情 | |
(XIII) | 34379 | (3S,10R,16S)-10-(4-amino-3-chlorobenzyl)-3-isobutyl-6,6-dimethyl-16-[(1R,2E)-1-methyl-3-phenyl-2-propenyl]-1,4-dioxa-8,11-diaza-13-cyclohexadecene-2,5,9,12-tetrone | C35H44ClN3O6 | 详情 | 详情 | |
(XIV) | 34380 | 9H-fluoren-9-ylmethyl 2-chloro-4-([(3S,10R,16S)-3-isobutyl-6,6-dimethyl-16-[(1R,2E)-1-methyl-3-phenyl-2-propenyl]-2,5,9,12-tetraoxo-1,4-dioxa-8,11-diaza-13-cyclohexadecen-10-yl]methyl)phenylcarbamate | C50H54ClN3O8 | 详情 | 详情 |